Idiopathic Pulmonary Fibrosis Cohort of TCM

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 5, 2025

Primary Completion Date

October 30, 2028

Study Completion Date

November 30, 2028

Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Interventions
DRUG

Traditional Chinese medicine (TCM)

Regulated use of Chinese medicine treatment protocols is included as an exposure factor. Exposure is defined as taking the medication continuously for more than 3 months per year, or intermittently for more than 6 months per year. According to the standardised use of TCM protocols, the group is divided into an exposed group (TCM cohort) and an unexposed group (non-TCM cohort).

DRUG

Non-traditional Chinese medicine (non-TCM)

All intervention measures that do not meet the criteria for TCM exposure are regarded as non-TCM exposure.

Trial Locations (1)

450000

The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

OTHER

collaborator

China-Japan Friendship Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Shanghai Pulmonary Hospital, Shanghai, China

OTHER

lead

Henan University of Traditional Chinese Medicine

OTHER

NCT07162870 - Idiopathic Pulmonary Fibrosis Cohort of TCM | Biotech Hunter | Biotech Hunter